Eton Pharmaceuticals (ETON) PT Lowered to $11 at B.Riley on CRL
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Price: $50.95 --0%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
B.Riley analyst Andrew D\'Silva lowered the price target on Eton Pharmaceuticals (NASDAQ: ETON) to $11.00 (from $13.00) while maintaining a Buy rating on CRL.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eton Pharma licenses IGF-1 patent for epileptic spasms study
- VICI Properties Inc. (VICI) PT Lowered to $29 at Cantor Fitzgerald
- Arista Networks (ANET) PT Raised to $261; Piper Sandler Reiterates 'Top Pick'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
